Students interested in advancing the scientific knowledge of biological mechanisms underlying symptom pathology in anorexia nervosa will, in this project, develop better methods for monitoring and evaluating core symptoms of the disease.
This is a double-blind, placebo controlled study of Risperidone for the treatment of anorexia nervosa. The study involves a monthly assessment of body image, body satisfaction, anxiety, and severity of eating disorder symptoms while subjects are taking Risperidone or placebo. The study includes use of the Body Image Software (BIS) program to evaluate body image distortion. The study began in 2004 and continues with a target enrollment of 50 subjects over three years.
Dr. Hagman is also developing a study specific to the BIS program which would be independent of the Risperidone study, and would include subjects with bulima nervosa and eating disorders not otherwise specified in males. We are in the process of validating the “Ease of Eating Scale (EOE). This scale was developed by Dr. Hagman to measure the severity of specific eating behaviors associated with eating disorders.
Preceptor Information |
|
| Name: | Jennifer Hagman, MD |
| Department: | Psychiatry/Child Psychiatry |
| Location: | The Children's Hospital 13123 E16th ave Aurora, CO
|
| Contact: | 720-777-1234 |
| hagman.jennifer@tchden.org | |
| Faculty/Lab Website: | |
Position Information |
|
| Openings | 1 |
| Funding: | Funding may be available at a later date |